Speakers

Elizabeth Allen

Senior Scientist II

DJS Antibodies Ltd

Judith Altarejos

Director; Obesity, Muscle and Metabolic Diseases

Regeneron

Luis Alvarez-Vallina

Head of Clinical Research Unit

Spanish National Cancer Research Centre

Jan Terje Andersen, Ph.D.

Professor, University of Oslo and Group Leader

Oslo University Hospital

Stephen Beers, PhD

Professor of Immunology and Immunotherapy

University of Southampton

Dennis Berlinger, PhD

Assistant Professor, Center for Translational Immu

UMC Utrecht

Carla Cano

R&D Lead Discovery Director

Imcheck Therapeutics

Kerry Chester, PhD

Professor of Molecular Medicine

UCL Cancer Institute

Silvia Crescioli, PhD

Visiting Research Fellow, King’s College London & Independent Consultant

The Antibody Society

Rony Dahan, PhD

Principal Investigator

Weizmann Institute of Science

Joe de Rutte, PhD

Co-Founder and President

Partillion Bioscience

Charlotte Deane, PhD

Professor of Structural Bioinformatics

University of Oxford

Mahendra Deonarain, PhD

Chief Executive and Science Officer

Antikor Biopharma Ltd

James Ernst, Ph.D.

Vice President, Head of Development Sciences

Xencor

Anne Goubier

SVP Research and Early Development

Molecular Partners AG

Dr. Jane Grogan, PhD

Executive Vice President & Head of Research

Biogen

Katherine Harris, PhD

Chief Development Officer

Rondo Therapeutics

Albert Heck, PhD

Professor of Chemistry and Pharmaceutical Sciences

Utrecht University

Manjunath Hegde, PhD

Team Leader, Technology Unit - Antibody Discovery

Iontas

Rene Hoet, Ph.D.

Chief Innovation Officer

FairJourney Biologics

Mark Hogarth, PhD

Professor and Burnet Senior Principal Research Fellow

Burnet Institute

Dr. Andreea Ioan-Facsinay, PhD

Director

Genmab

Leo James, PhD

MRC Programme Leader

MRC Laboratory of Molecular Biology

Sophia Karagiannis, Ph.D.

Professor of Translational Cancer Immunology and Immunotherapy

King's College London School of Medicine

Dr. Justin Killebrew, PhD

Vice President of Biology

Bonum Therapeutics

Christian Klein, PhD

CXO in Residence & Drug Hunter

Curie.Bio

Friedrich Koch-Nolte, PhD

Professor of Immunology and Molecular Biology

University Medical Center Hamburg-Eppend

Harald Kolmar, PhD

Professor and Head of Applied Biochemistry

TU Darmstadt

Dr. Eric Krauland, PhD

President and Chief Scientific Officer

Adimab

Daniëlle Krijgsman, PhD

Assistant Professor

UMC Utrecht

Taichi Kuramochi

Head of Biologics Discovery Department

Chugai Pharmaceutical Co., Ltd.

Jeanette Leusen, PhD

Associate Professor, Head Immunotherapy Group

University Medical Center Utrecht

Tara Mahon, PhD

Associate Director, Research - Protein Science Pip

Immunocore

Sean McClain

Chief Technology Officer

Absci LLC

Kristy McHugh, PhD

Senior Postdoctoral Scientist

University of Oxford

Dr. Kathryn (Kate) Monroe, PhD

Director and Principal Scientist

Denali Therapeutics

Phil Noble, PhD

Head of Single B Cell Antibody Discovery

UCB

Jane Osbourn, PhD

CEO

Alchemab Therapeutics

Anna Park, PhD

Distinguished Scientist, Protein Engineering Group Head, LMR US

Sanofi

Niccolo Pengo, PhD

Chief Scientific Officer

Mabylon AG

Mario Perro, PhD

Head of Biologics Research & Site Head, SVP

Ichnos Glenmark Innovation

Ben Porebski, PhD

CEO & CTO

Sortera Bio

Dr. Johannes Preiner, PhD

Research Group Leader

University of Applied Sciences Upper Austria

Alfredo Quijano Rubio

Chief Scientific Officer

Monod Bio

Sai Reddy, PhD

Associate Professor of Systems and Synthetic Immunology

ETH Zurich

Marc Robillard, PhD

CSO & founder

Tagworks Pharmaceuticals

Jose-Ignacio Rodriguez-Barbosa, PhD

Associate Professor of Immunology

University of Leon

Simone Schmitt, PhD

Vice President, Technology & Operations

Memo Therapeutics AG

Janine Schuurman, Ph.D.

Biotech Consultant

Lust for Life Science

Karen Silence, PhD

Head Preclinical Product Development

Argenx

Jonathan Sockolosky, PhD

Senior Director, CSO Partner Team

Curie.Bio

Anette Sommer, PhD

Head of Biochemistry

Synaffix BV

Dr. Dale Starkie, PhD

Director

DJS Antibodies

Edward Tate

Professor of Chemical Biology

Imperial College London

Nathan Tumey, PhD

Associate Professor, Pharmaceutical Sciences

Binghamton University

Obinna Ubah, PhD

Principal Scientist and Future Leaders Fellow

Elasmogen Limited

Thomas Valerius, MD

Professor, Faculty of Medicine

University Hospital Schleswig-Holstein

Ellen Wagner, PhD

Director of Research

GigaGen

Sally Ward, PhD

Professor and Director

University of Southampton

Dr. Stefan Weise, PhD

Postdoctoral Scientist

Roche Diagnostics GmbH

Ann White

Senior Director of Translational Science

Mestag Therapeutics